Literature DB >> 9684114

Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage.

T Akiyama1, T Hasegawa, T Sejima, H Sahara, K Seto, H Saito, S Takashima.   

Abstract

BACKGROUND/AIMS: This study was designed to assess the correlation of interleukin 6 (IL-6) with jaundice reduction by percutaneous transhepatic cholangio-drainage (PTCD) for obstructive jaundice.
METHODOLOGY: We measured serum and bile IL-6 concentrations by enzyme linked immuno-sorbent assay before and after PTCD in 26 patients with obstructive jaundice. The patients were divided into two groups according to their bilirubin decrease rate.
RESULTS: Serum IL-6 levels measured before and after PTCD in the slowly decreasing bilirubin group ("poor" group) were significantly higher than those of the rapidly decreasing bilirubin group ("good" group). Measures of bile IL-6 in the "poor" group remained high from 3 to 14 days after PTCD in comparison with the "good" group.
CONCLUSIONS: These results suggest that circulating IL-6, as well as IL-6 in the bile, may be involved in the pathogenesis of obstructive jaundice, and play an important role in preventing the resolution of obstructive jaundice after PTCD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684114

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

Review 1.  Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.

Authors:  A-J Demetris; John-G Lunz; Susan Specht; Isao Nozaki
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

2.  Diagnostic and therapeutic potentials of microRNAs in cholangiopathies.

Authors:  Indsey Kennedy; Heather Francis; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  Liver Res       Date:  2017-04-26

3.  Molecular mechanisms of cholangiocarcinoma.

Authors:  Giammarco Fava
Journal:  World J Gastrointest Pathophysiol       Date:  2010-04-15

4.  Regulation and function of trefoil factor family 3 expression in the biliary tree.

Authors:  Isao Nozaki; John G Lunz; Susan Specht; Jong-In Park; Andrew S Giraud; Noriko Murase; Anthony J Demetris
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 5.  Obesity and cholangiocarcinoma.

Authors:  Mansour A Parsi
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

6.  Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.

Authors:  Fanyin Meng; Yoko Yamagiwa; Yoshiyuki Ueno; Tushar Patel
Journal:  J Hepatol       Date:  2005-12-13       Impact factor: 25.083

7.  Risk factors of organ failure in patients with bacteremic cholangitis.

Authors:  Ban Seok Lee; Jin-Hyeok Hwang; Sang Hyub Lee; Sang Eon Jang; Eun Sun Jang; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Jin-Wook Kim; Sook-Hyang Jung; Nayoung Kim; Dong Ho Lee; Jun Kyu Lee; Soyeon Ahn
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

8.  Molecular pathogenesis of cholangiocarcinoma.

Authors:  G Fava; I Lorenzini
Journal:  Int J Hepatol       Date:  2011-07-21

9.  Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.

Authors:  K-Y Lin; H Ye; B-W Han; W-T Wang; P-P Wei; B He; X-J Li; Y-Q Chen
Journal:  Oncogene       Date:  2015-10-12       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.